Vanta Bioscience Ltd., a preclinical contract research organisation based in Hyderabad and having research laboratories in Chennai, has entered into an exclusive agreement with Hongkong ThinkWay Trading Ltd., Hongkong, to expand its business in the pre-clinical services sector in Greater China.
It have also entered into non-exclusive agreements to cover the markets of Latin America and Asia Pacific for chemicals and agrochemical business. These are lucrative markets and Vanta Bioscience expects over 25% of its revenues this year to come from this initiative.
The company believes that this association will help in obtaining key clients and further business opportunities in China and fuel its growth prospects, a release from Vanta Bioscience on Tuesday said. Managing Director M. Dopesh Raja said the expansion into China, APAC and LATAM markets would help secure long-term contracts.